1 Bright Minds Biosciences Inc Receivables Turnover Ratio (DRUG), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

At a Glance

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Bright Minds Biosciences Inc (NASDAQ: DRUG)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Bright Minds Biosciences Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics

According to Bright Minds Biosciences Inc Balance Sheet, in the third quarter 2026, company has not reported any Accounts receivable.
See Bright Minds Biosciences Inc Balance Sheet

If we take a look into Healthcare sector Bright Minds Biosciences Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Bright Minds Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DRUG Receivables Turnover Ratio	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	-	-	-	-	-
DRUG's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

DRUG Company Profile • Back to DRUG Efficiency Comparisons • Compare DRUG Receivables Turnover Ratio to its Competitors

Financial Statements
Bright Minds Biosciences Inc 's Accounts Receivable	$ 0 Millions	Visit DRUG's Balance sheet
Bright Minds Biosciences Inc 's Sales TTM	$ 0 Millions	Visit DRUG's Income Statement
Sources of DRUG's Revenues		Visit DRUG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DRUG's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DRUG's Growth Rates	DRUG's Roa	DRUG's Inventory Turnover Ratio	DRUG's Dividend Comparisons
DRUG's Profitability Ratios	DRUG's Roi	DRUG's Asset Turnover Ratio	DRUG's Dividend Growth
DRUG's Valuation Ratios	DRUG's Roe	DRUG's Financial Strength Ratios	DRUG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Jun 30 2026

Receivable at quarter ending Jun 30 2026

Date modified: 2026-10-15T05:23:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.